Brazil Contraceptive Devices Market Size

Brazil Contraceptive Devices Market Analysis

The Brazil contraceptive devices market is expected to register a CAGR of 6.7% over the forecast period.

• COVID-19 was a global health emergency. The COVID-19 pandemic forced many companies in global contraceptive manufacturers to halt business operations for a short term to comply with new government regulations to curb the spread of the disease. This halt in operations directly impacted the revenue flow of the Brazilian contraceptive device market. For instance, in an article published in The European Journal of Contraception & Reproductive Health Care in February 2022, during the early phase, there was a decline in the use of contraceptives due to the temporary closure of clinics, and the sales of contraceptives fell during 2020. However, according to the same source, during the late pandemic, the increase in sales of the levonorgestrel-releasing intrauterine system (LNG-IUS) and etonogestrel (ENG) implant in the private sector indicated inequitable access to modern contractive methods, thereby driven the market growth. Therefore, Brazil's contraceptive devices market is anticipated to witness slow growth during the initial phase of the pandemic; however, post-pandemic, the market attained its pace and witnessed significant growth and is expected to do the same over the forecast period.
• The factors that are driving the Brazilian contraceptive devices market are the increasing incidence of sexually transmitted diseases (STDs) and a rise in unplanned pregnancies.
• Sexually transmitted infections (STIs), including Human immunovirus (HIV), syphilis, chlamydia, gonorrhea, trichomoniasis, and genital herpes, are major public health problems in Brazil. For instance, according to Brazilian Health Data, the number of outpatients in public hospitals in Brazil with unspecified HIV was 68,941in May 2023. Furthermore, according to an article published in the Journal of the Brazilian Society of Tropical Medicine in May 2021 reported the high prevalence of sexually transmitted diseases in Brazil, and there is a need for expanding access to diagnostic tests, and early treatment is crucial for controlling the spread of pathogens that cause cervicitis.
• An unintended pregnancy occurs from not using contraception or by inconsistent and incorrect use of contraceptive methods. The growth of the contraceptive market is a necessity to avoid unwanted pregnancies and their complications, especially among teenagers. For instance, in an article published in Frontiers in Public Health in April 2021, approximately 12 million adolescents aged 15-19 years, 770 thousand of whom are under 15 years, give birth each year in the developing world. Thus, high adolescent and unplanned pregnancies are anticipated to drive the market for contraceptive devices in the country. Also, governments and policymakers in the country are addressing sexually transmitted infections (STIs) among young people through high-quality sex education programs, access to clinical care, preventive technologies and vaccines, and confidential services. All these initiatives are making young people aware of sexually transmitted diseases (STDs) and thus increasing the need for contraceptive devices, thereby driving the market.
• Therefore, due to factors such as the huge prevalence of sexually transmitted diseases and rising unplanned pregnancies, the Brazil contraceptive devices market is expected to show significant growth over the forecast period. However, side effects associated with using contraceptive devices may slow down the market growth over the studied period.